Complete Emergency Care La Vernia Llc

CLIA Laboratory Citation Details

4
Total Citations
27
Total Deficiencyies
14
Unique D-Tags
CMS Certification Number 45D2104701
Address 102 S Fm 1346, Suite 2, La Vernia, TX, 78121
City La Vernia
State TX
Zip Code78121
Phone(830) 253-5099

Citation History (4 surveys)

Survey - January 7, 2026

Survey Type: Special

Survey Event ID: JZU311

Deficiency Tags: D0000 D2096 D6016 D2016 D6000

Summary:

Summary Statement of Deficiencies D0000 The following deficiencies are a result of a desk review of proficiency testing scores obtained from the national database and verified with the proficiency testing company. The facility was found to be out of compliance with the conditions of the CLIA program. The following CONDITION LEVEL DEFICIENCIES were found: D2016 - 42 C.F.R. 493.803 Condition: Successful participation [proficiency testing] D6000 - 42 C.F.R. 493.1403 Condition: Laboratories performing moderate complexity testing; laboratory director D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- (CASPER) Report 155 Individual Laboratory Profile and American Proficiency Institute's proficiency reports, the laboratory failed to achieve satisfactory performance in two of two testing events for the analyte of CK, isoenzymes (refer to D2096) resulting in an initial unsuccessful performance. D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) (f) Failure to achieve satisfactory performance for the same analyte or test in two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: 1. A review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 155 Individual Laboratory Profile report, the laboratory received the following unsatisfactory performances for CK, isoenzymes on two of two events: 2025 Event 2 40% 2025 Event 3 60% 2. A review of the American Proficiency Institute's proficiency testing reports from 2025 confirmed the findings. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on proficiency testing desk review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 155 Individual Laboratory Profile and the American Proficiency Institute's proficiency testing reports from 2025 (Events 2 and 3), the laboratory director failed to provide overall management and direction of the laboratory services resulting in an initial proficiency testing failure for the analyte CK, isoenzymes (refer to D6016.) D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) (e)(4)(i) The proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on proficiency desk review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 155 Individual Laboratory Profile and the American Proficiency Institute's proficiency testing reports from 2025 (Events 2 and 3), the laboratory director failed to ensure successful participation in a HHS approved proficiency testing program for the analyte of CK, isoenzymes for two of two events in 2025, resulting in an initial unsuccessful performance (refer to D2096). -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 17, 2024

Survey Type: Standard

Survey Event ID: 223Q11

Deficiency Tags: D5401 D5401

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on review of the laboratory's procedures, review of patient test records from 09 /30/2024 to 10/14/2024, and staff interview, the laboratory failed to have documentation of following its policy for addressing flags on 5 of 5 platelet results. The findings included: 1. The laboratory's procedure titled "CBC Sysmex XP-300" (effective 10/21/2021) under the section titled "Platelet Flags" stated: "Any platelet count >50 with AG flags will be repeated on the original properly obtained and well mixed sample. The platelet count will be reported as usual if the AG Flag disappears and a similar platelet count results is obtained upon repeat analysis... (If the flag repeats) The original platelet results should be masked before providing the physician with the CBC results." 2. A review of the patient test records from 09/30/2024 to 10/14 /2024 identified 5 of 5 flagged platelet results reported to the provided without being masked as required by the laboratory's procedure. They were: Date: 09/30/2024 Sample ID: 093009 Date: 10/02/2024 Sample ID: 100202 Date: 10/05/2024 Sample ID: 100501 Date: 10/08/2024 Sample ID: 100804 Date: 10/14/2024 Sample ID: 101413 3. The technical consultant confirmed the findings in an interview conducted on 10/17/2024 at 1130 hours in the break room. Key CBC - complete blood count ID - identification Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 4, 2022

Survey Type: Standard

Survey Event ID: 62LG11

Deficiency Tags: D0000 D2009 D2010 D5813 D6055 D6063 D6065 D6066 D0000 D2009 D2010 D5813 D6055 D6063 D6065 D6066

Summary:

Summary Statement of Deficiencies D0000 The laboratory was found to be out of compliance based on the following CONDITION LEVEL DEFICIENCY: D6063 - 42 C.F.R. 493.1421 Condition: Testing Personnel Noted deficiencies and plans of correction were discussed with the laboratory representative at the exit conference. The facility representative was given an opportunity to provide evidence of compliance with noted deficiencies and no such evidence was provided prior to survey exit. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 27, 2021

Survey Type: Standard

Survey Event ID: JED611

Deficiency Tags: D0000 D5449 D0000 D5449

Summary:

Summary Statement of Deficiencies D0000 Noted deficiencies and plans of correction were discussed with the laboratory representative at the entrance and exit conferences. The facility representative was given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. The facility was found to be in compliance with applicable Conditions of Participation in the CLIA program, and recertification is recommended. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access